查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541500

2024-2032 年按产品、技术、测试类型和地区分類的新生儿筛检市场报告

Newborn Screening Market Report by Product, Technology, Test Type, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球新生儿筛检市场规模达到 10.266 亿美元。个人对早期发现新生儿严重疾病的意识不断增强、医疗技术的进步以实现更准确的结果以及有利的政府倡议是推动市场成长的一些关键驱动力。

全球新生儿筛检市场分析：

主要市场驱动因素：代谢和遗传疾病的日益普及以及出生率的提高主要推动了新生儿筛检市场份额的成长。除此之外，对可降低医疗成本和改善结果的筛检测试的需求不断增加，也是另一个重要的成长诱导因素。

主要市场趋势：资料管理和分析工具的不断整合以提高新生儿筛检的效率是支撑新生儿筛检市场前景的新兴趋势之一。此外，父母对预防性医疗措施和整体福祉的日益重视进一步推动了新生儿筛检市场需求。

地理趋势：根据新生儿筛检市场研究报告，由于拥有先进的医疗基础设施，北美表现出明显的主导地位。除此之外，有利的政府措施和法规正在进一步积极影响区域市场。

竞争格局：全球新生儿筛检市场的一些主要参与者包括 Agilent Technologies Inc.、Baebies Inc.、Bio-RAD Laboratories Inc.、Chromsystems Instruments & Chemicals GmbH、Danaher Corporation、Masimo Corporation、Medtronic plc、Natus Medical Incorporated、 Perkinelmer Inc.、RECIPE Chemicals + Instruments GmbH、Thermo Fisher Scientific Inc.、Trivitron Healthcare 和Waters Corporation 等。

挑战与机会：阻碍​​新生儿筛检市场的主要挑战之一是许多国家和地区的新生儿筛检测试缺乏标准化。除此之外，法律和道德方面的考虑，包括资料隐私和同意，可能会为扩大和实施新生儿筛检计画带来挑战。然而，确保有效解决各种潜在健康问题的有利措施的推出预计将在预测期内扩大全球市场。

全球新生儿筛检市场趋势：

提高早期疾病检测意识

父母越来越意识到早期疾病检测的重要性，因为它有助于提高治疗效果、改善儿童的生活品质、提供及时介入等，这是推动新生儿筛检市场的主要驱动力之一。除此之外，先天性疾病发生率的上升也是另一个重要的生长诱导因素。例如，根据世界卫生组织2023年2月公布的资料，全球每年估计有24万名新生儿在出生后28天内因先天性疾病死亡。此外，根据印度儿科的讯息，印度每1,000名婴儿中就有2.1人患有先天性甲状腺功能减退症，先天性代谢异常的盛行率为2-7.8%。

有利的政府倡议

监管机构推出的政策通常涵盖一系列全面的疾病，并确保有效解决潜在的健康问题，这正在提振全球新生儿筛检市场。例如，2022 年 6 月，加拿大马尼托巴省政府机构宣布扩大新生儿筛检计划，旨在扩大脊髓性肌肉萎缩症以及其他疾病的筛检范围。此外，各政府部门也强制新生儿出院前进行筛检，进而对整体市场成长产生正面影响。例如，根据 2021 年的《March of Dimes》（MoD）报告，美国的每个婴儿在离开医院之前都经过了筛选过程。此外，德州、加州和纽约州的新生儿筛检计画也在美国各地获得了广泛关注，这将在预测期内继续推动新生儿筛检市场。

医疗科技的进步

主要参与者正在改进他们的医疗技术，以改善新生儿筛检方法，这是另一个重要的生长诱导因素。此外，新兴的筛检技术鼓励医疗保健提供者提供和​​采用这些服务，从而推动全球市场的发展。例如，2021 年 6 月，德州卫生与公众服务部推出了新生儿脊髓性肌肉萎缩症 (SMA) 筛检。为此，Trivitron Healthcare 在印度 AMTZ 园区建立了卓越中心 (CoE)，拥有最先进的研发和製造设施，用于基因组学、新生儿筛检、代谢组学和分子诊断。此外，2023 年 1 月，Masimo 宣布推出全新的最先进的婴儿监控系统，让护理人员能够即时监控婴儿的资料。

全球新生儿筛检市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品、技术和测试类型对市场进行了分类。

按产品划分：

仪器仪表

试剂

仪器代表最大的细分市场

该报告根据产品提供了详细的市场细分和分析。这包括仪器和试剂。报告显示，仪器仪表占据最大的市场份额。

仪器在样本采集、分析、结果解释等筛选过程中发挥至关重要的作用。此外，主要医疗保健公司对需要仪器的诊断测试的投资不断增加，预计将推动这一细分市场的成长。例如，2023 年 3 月，GC Labs 宣布推出整合新疾病检测方法的新测试，用于诊断新生儿先天性代谢错误 (IEM)。

按技术划分：

串联质谱法

脉搏血氧仪

基于酵素的测定

DNA检测

电泳

其他的

串联质谱占据大部分市场份额

该报告基于该技术对市场进行了详细的细分和分析。这包括串联质谱法、脉搏血氧测定法、酵素测定法、DNA 测定法、电泳法等。报告称，串联质谱占据了最大的市场份额。

串联质谱法是指用于新生儿筛检以识别多种代谢紊乱的分析技术。与此一致的是，它提供了更高的准确性和速度。医疗领域的众多技术进步增强了串联质谱分析技术，这将继续推动该细分市场的成长。例如，2023年4月，沃特世公司宣布开发出用于临床应用的新型Xevo TQ绝对IVD质谱仪。

按测试类型划分：

干血斑测试

慢性心臟衰竭

听力筛检

干血斑检测占最大市场份额

该报告根据测试类型提供了详细的市场细分和分析。这包括干血斑测试、CCHD 和听力筛检。报告称，干血斑检测占据最大的市场份额。

干血斑测试是指一种非侵入性筛检技术，通常涉及从新生儿脚跟收集少量血液到特殊滤纸上。然后分析干燥的血液样本中是否存在与多种疾病相关的特定标记。该测试在新生儿筛检计画中广受青睐，因为它运输方便、样本采集方便，并且能够同时筛检各种情况。除此之外，政府机构的措施数量不断增加是这一细分领域另一个重要的成长诱导因素。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美市场领先，占据最大的新生儿筛检市场份额

市场研究报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据最大的市场份额。

北美先天性残疾的盛行率不断上升，增加了新生儿筛检的需求。此外，该地区政府机构实施严格的法规也是另一个重要的成长诱导因素。例如，根据2021年的March of Dimes (MoD)报告，美国的每个婴儿在离开医院之前都经过了筛选过程。除此之外，主要参与者对预防性医疗保健的日益关注正在推动先进技术的普及，预计这将在可预见的未来提振北美新生儿筛检市场。

竞争格局：

各製造商正在投资研发 (R&D) 活动，以提供创新的筛选技术和方法。这包括改进串联质谱等现有技术，并探索新方法来扩大检测条件的范围。此外，公司还透过在测试组中添加更多条件来提供更全面的筛选服务。除此之外，主要参与者也专注于开发自动化系统，以简化从样本收集到结果解释的筛选过程，以提高效率、减少人为错误并缩短週转时间。

市场研究报告对竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

安捷伦科技公司

宝贝公司

Bio-RAD 实验室公司

Chromsystems 仪器与化学品有限公司

丹纳赫公司

马西莫公司

美敦力公司

内特斯医疗公司

珀金内尔默公司

RECIPE 化学品+仪器有限公司

赛默飞世尔科技公司

Trivitron 医疗保健

沃特世公司

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

全球新生儿筛检市场新闻：

2024 年 3 月：世界卫生组织 (WHO) 在东南亚推出了针对新生儿眼部异常、听力障碍和新生儿黄疸进行普遍筛检的实施指南。

2024 年 2 月：海得拉巴的 Niloufer 医院推出了一项新生儿筛检计划，以检测罕见的遗传状况。

2024 年2 月：一项名为「早期检查」的研究对1,000 名出生后的新生儿进行了筛检，以提供治疗、向父母提供教育资讯、及早发现罕见疾病，并将家庭与整个北卡罗来纳州的专家联繫起来。

本报告回答的关键问题

  • 2023年全球新生儿筛检市场规模有多大
  • 2024-2032年全球新生儿筛检市场的预期成长率是多少
  • 推动全球新生儿筛检市场的关键因素是什么
  • COVID-19 对全球新生儿筛检市场有何影响
  • 基于产品的全球新生儿筛检市场区隔是怎样的
  • 基于该技术的全球新生儿筛检市场的细分如何
  • 根据测试类型，全球新生儿筛检市场的细分如何
  • 全球新生儿筛检市场的重点区域有哪些
  • 谁是全球新生儿筛检市场的主要参与者/公司

本报告回答的关键问题

  • 2023年全球新生儿筛检市场规模有多大？ 2024-2032年全球新生儿筛检市场的预期成长率是多少？
  • 推动全球新生儿筛检市场的关键因素是什么？
  • COVID-19 对全球新生儿筛检市场有何影响？
  • 基于产品的全球新生儿筛检市场的细分情况如何？
  • 基于该技术的全球新生儿筛检市场的细分情况如何？
  • 根据测试类型，全球新生儿筛检市场的细分如何？
  • 全球新生儿筛检市场的重点区域有哪些？
  • 全球新生儿筛检市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球新生儿筛检市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 仪器仪表
    • 市场趋势
    • 市场预测
  • 试剂
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依技术

  • 串联质谱法
    • 市场趋势
    • 市场预测
  • 脉搏血氧仪
    • 市场趋势
    • 市场预测
  • 基于酵素的测定
    • 市场趋势
    • 市场预测
  • DNA检测
    • 市场趋势
    • 市场预测
  • 电泳
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按测试类型

  • 干血斑测试
    • 市场趋势
    • 市场预测
  • 慢性心臟衰竭
    • 市场趋势
    • 市场预测
  • 听力筛检
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Baebies Inc.
    • Bio-RAD Laboratories Inc.
    • Chromsystems Instruments & Chemicals GmbH
    • Danaher Corporation
    • Masimo Corporation
    • Medtronic plc
    • Natus Medical Incorporated
    • Perkinelmer Inc.
    • RECIPE Chemicals + Instruments GmbH
    • Thermo Fisher Scientific Inc.
    • Trivitron Healthcare
    • Waters Corporation
Product Code: SR112024A4068

The global newborn screening market size reached US$ 1,026.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,777.7 Million by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032. The increasing awareness among individuals towards early detection of severe diseases in newborns, improvements in medical technology for more accurate outcomes, and favorable government initiatives represent some of the key drivers bolstering the market growth.

Global Newborn Screening Market Analysis:

Major Market Drivers: The growing prevalence of metabolic and genetic disorders and the increasing birth rates are primarily driving the newborn screening market share. Apart from this, the escalating demand for screening tests that provide reduced healthcare costs and improved outcomes is also acting as another significant growth-inducing factor.

Key Market Trends: The rising integration of data management and analysis tools to improve the efficiency of newborn screening is one of the emerging trends bolstering the newborn screening market outlook. Additionally, the inflating emphasis on preventive healthcare measures and holistic well-being among parents is further propelling the newborn screening market demand.

Geographical Trends: According to the newborn screening market research report, North America exhibits a clear dominance, owing to the presence of advanced healthcare infrastructures. Besides this, favorable government initiatives and regulations are further positively influencing the regional market.

Competitive Landscape: Some of the key players in the global newborn screening market include Agilent Technologies Inc., Baebies Inc., Bio-RAD Laboratories Inc., Chromsystems Instruments & Chemicals GmbH, Danaher Corporation, Masimo Corporation, Medtronic plc, Natus Medical Incorporated, Perkinelmer Inc., RECIPE Chemicals + Instruments GmbH, Thermo Fisher Scientific Inc., Trivitron Healthcare, and Waters Corporation, among many others.

Challenges and Opportunities: One of the primary challenges hindering the newborn screening market is the lack of standardization in newborn screening tests across numerous countries and regions. Besides this, legal and ethical considerations, including data privacy and consent, can pose challenges in expanding and implementing newborn screening programs. However, the launch of favorable initiatives that ensure that a wide range of potential health issues are addressed efficiently is projected to augment the global market over the forecasted period.

Global Newborn Screening Market Trends:

Increasing Awareness about Early Disease Detection

The growing awareness among parents towards the critical importance of early disease detection, as it helps in enhancing treatment outcomes, improving quality of life for the child, offering timely intervention, etc., represents one of the primary drivers bolstering the newborn screening market. Besides this, the rising occurrence of congenital diseases is also acting as another significant growth-inducing factor. For example, according to the data published by the WHO in February 2023, an estimated 240,000 newborns die within 28 days of birth each year globally due to congenital diseases. Moreover, according to the information from Indian Pediatrics, congenital hypothyroidism occurs in 2.1 out of every 1,000 infants in India, and the prevalence of inborn metabolic abnormalities ranges from 2-7.8%.

Favorable Government Initiatives

The launch of policies by regulatory authorities that often cover a comprehensive panel of disorders and ensure that potential health issues are addressed efficiently is bolstering the global newborn screening market. For example, in June 2022, government bodies in Manitoba, Canada, announced the expansion of their newborn screening program with an aim to extend screening for spinal muscular atrophy, along with other diseases. Moreover, various government authorities have also made newborn screening compulsory before getting discharged from the hospital, thereby positively impacting the overall market growth. For instance, according to the March of Dimes (MoD) report of 2021, before leaving the hospital, every baby in the United States went through the screening process. Furthermore, newborn screening programs in Texas, California, and New York also gained extensive traction across the U.S., which will continue to drive the newborn screening market over the forecasted period.

Improvements in Medical Technology

Key players are advancing their medical technologies to improve newborn screening methods, which is acting as another significant growth-inducing factor. Moreover, emerging screening technologies encourage healthcare providers to offer and adopt these services, thereby fueling the global market. For example, in June 2021, the Texas Health and Human Services introduced newborn screening for Spinal Muscular Atrophy (SMA). In line with this, Trivitron Healthcare developed a Centre of Excellence (CoE) with state-of-the-art R&D and manufacturing facilities at AMTZ Campus in India for genomics, newborn screening, metabolomics, and molecular diagnostics. Furthermore, in January 2023, Masimo announced the launch of its new state-of-the-art baby monitoring system that allows caretakers to monitor the data of babies in real-time.

Global Newborn Screening Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, technology and test type.

Breakup by Product:

Instruments

Reagents

Instruments represent the largest market segment

The report has provided a detailed breakup and analysis of the market based on the product. This includes instruments and reagents. According to the report, instruments accounted for the largest market share.

Instruments play a crucial role in the screening process for sample collection, analysis, result interpretation, etc. In addition to this, they comprise a wide array of technologies, such as deoxyribonucleic acid (DNA) analyzers, automated screening platforms, mass spectrometry systems, etc. Moreover, the rising investments by key healthcare companies in diagnostics tests that require instruments are expected to bolster the market growth in this segmentation. For instance, in March 2023, GC Labs announced the launch of its new test for the diagnosis of Inborn Errors of Metabolism (IEM) among newborns with the integration of novel disease detection methods.

Breakup by Technology:

Tandem Mass Spectrometry

Pulse Oximetry

Enzyme Based Assay

DNA Assay

Electrophoresis

Others

Tandem mass spectrometry accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the technology. This includes tandem mass spectrometry, pulse oximetry, enzyme based assay, DNA assay, electrophoresis, and others. According to the report, tandem mass spectrometry accounted for the largest market share.

Tandem mass spectrometry refers to an analytical technique that is employed in newborn screening to identify several metabolic disorders. In line with this, it provides improved accuracy and speed. Numerous technological advancements in the medical field enhance tandem mass spectrometry, which will continue to drive the market growth in this segmentation. For example, in April 2023, Waters Corporation announced the development of its new Xevo TQ Absolute IVD Mass Spectrometer for clinical applications.

Breakup by Test Type:

Dry Blood Spot Test

CCHD

Hearing Screen

Dry blood spot test holds the biggest market share

The report has provided a detailed breakup and analysis of the market based on the test type. This includes dry blood spot test, CCHD, and hearing screen. According to the report, the dry blood spot test accounted for the largest market share.

A dry blood spot test refers to a non-invasive screening technique that generally involves collecting a small amount of blood from the heel of a newborn onto a special filter paper. The dried blood sample is then analyzed for the presence of specific markers associated with several disorders. The test is widely preferred among newborn screening programs, as it provides ease of transportation, convenience of sample collection, and the ability to simultaneously screen for various conditions. Besides this, the elevating number of initiatives by government bodies is acting as another significant growth-inducing factor in this segmentation.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest newborn screening market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The increasing prevalence of congenital disabilities in North America is augmenting the need for newborn screening. Moreover, the implementation of stringent regulations by government bodies across the region is also acting as another significant growth-inducing factor. For example, according to the March of Dimes (MoD) report of 2021, before leaving the hospital, every baby in the United States went through the screening process. Apart from this, the elevating focus of key players on preventive healthcare is inflating the popularity of advanced technologies, which is expected to bolster the North America newborn screening market over the foreseeable future.

Competitive Landscape:

Various manufacturers are investing in research and development (R&D) activities to provide innovative screening technologies and methods. This includes refining existing techniques like tandem mass spectrometry and exploring new approaches to broaden the scope of conditions detected. In addition, companies are providing a more comprehensive screening service by adding more conditions to their test panels. Apart from this, key players are also focusing on developing automated systems that streamline the screening process, from sample collection to result interpretation, to enhance efficiency, reduce human error, and allow for faster turnaround times.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Baebies Inc.

Bio-RAD Laboratories Inc.

Chromsystems Instruments & Chemicals GmbH

Danaher Corporation

Masimo Corporation

Medtronic plc

Natus Medical Incorporated

Perkinelmer Inc.

RECIPE Chemicals + Instruments GmbH

Thermo Fisher Scientific Inc.

Trivitron Healthcare

Waters Corporation

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Global Newborn Screening Market News:

March 2024: The World Health Organization (WHO) launched implementation guidance in Southeast Asia for universal screening of eye abnormalities, hearing impairment, and neonatal jaundice among newborns.

February 2024: Niloufer Hospital in Hyderabad introduced a newborn screening program to detect rare genetic conditions.

February 2024: A research study titled Early Check has screened 1,000 newborns after birth to provide treatment, give parents educational information, identify rare conditions early, and connect families with specialists throughout the state of North Carolina.

Key Questions Answered in This Report

  • 1. What was the size of the global newborn screening market in 2023?
  • 2. What is the expected growth rate of the global newborn screening market during 2024-2032?
  • 3. What are the key factors driving the global newborn screening market?
  • 4. What has been the impact of COVID-19 on the global newborn screening market?
  • 5. What is the breakup of the global newborn screening market based on the product?
  • 6. What is the breakup of the global newborn screening market based on the technology?
  • 7. What is the breakup of the global newborn screening market based on the test type?
  • 8. What are the key regions in the global newborn screening market?
  • 9. Who are the key players/companies in the global newborn screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Newborn Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Tandem Mass Spectrometry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pulse Oximetry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Enzyme Based Assay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 DNA Assay
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Electrophoresis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Test Type

  • 8.1 Dry Blood Spot Test
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 CCHD
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hearing Screen
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baebies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Chromsystems Instruments & Chemicals GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Masimo Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Natus Medical Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Perkinelmer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 RECIPE Chemicals + Instruments GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Trivitron Healthcare
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Waters Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Newborn Screening Market: Major Drivers and Challenges
  • Figure 2: Global: Newborn Screening Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Newborn Screening Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Newborn Screening Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Newborn Screening Market: Breakup by Test Type (in %), 2023
  • Figure 7: Global: Newborn Screening Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Newborn Screening (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Newborn Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Newborn Screening (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Newborn Screening (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Newborn Screening (Tandem Mass Spectrometry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Newborn Screening (Tandem Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Newborn Screening (Pulse Oximetry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Newborn Screening (Pulse Oximetry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Newborn Screening (Enzyme Based Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Newborn Screening (Enzyme Based Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Newborn Screening (DNA Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Newborn Screening (DNA Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Newborn Screening (Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Newborn Screening (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Newborn Screening (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Newborn Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Newborn Screening (Dry Blood Spot Test) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Newborn Screening (Dry Blood Spot Test) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Newborn Screening (CCHD) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Newborn Screening (CCHD) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Newborn Screening (Hearing Screen) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Newborn Screening (Hearing Screen) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Newborn Screening Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Newborn Screening Industry: SWOT Analysis
  • Figure 80: Global: Newborn Screening Industry: Value Chain Analysis
  • Figure 81: Global: Newborn Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Newborn Screening Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Newborn Screening Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Newborn Screening Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Newborn Screening Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 5: Global: Newborn Screening Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Newborn Screening Market: Competitive Structure
  • Table 7: Global: Newborn Screening Market: Key Players